Burlington Stores (BURL) 10-Q 24 Nov 15 2016 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Oct. 31, 2015	Nov. 20, 2015
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Oct. 31, 2015
Document Fiscal Year Focus	2,016
Document Fiscal Period Focus	Q3
Trading Symbol	BURL
Entity Registrant Name	BURLINGTON STORES, INC.
Entity Central Index Key	1,579,298
Current Fiscal Year End Date	--01-30
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		75,952,146

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Oct. 31, 2015	Jan. 31, 2015	Nov. 01, 2014
Current assets:
Cash and cash equivalents	$ 28,847	$ 25,349	$ 29,437
Restricted cash and cash equivalents	27,800	27,800	32,100
Accounts receivable—net of allowance for doubtful accounts	49,018	49,716	53,484
Merchandise inventories	934,011	788,708	899,880
Deferred tax assets	36,934	37,229	18,216
Prepaid and other current assets	68,721	58,681	123,382
Total current assets	1,145,331	987,483	1,156,499
Property and equipment—net of accumulated depreciation and amortization	1,018,188	970,419	964,217
Tradenames	238,000	238,000	238,000
Favorable leases—net of accumulated amortization	248,210	266,397	272,807
Goodwill	47,064	47,064	47,064
Other assets	108,524	115,206	118,314
Total assets	2,805,317	2,624,569	2,796,901
Current liabilities:
Accounts payable	704,187	621,682	766,510
Other current liabilities	327,156	310,268	299,122
Current maturities of long term debt	1,376	1,167	13,275
Total current liabilities	1,032,719	933,117	1,078,907
Long term debt	1,412,431	1,249,276	1,410,838
Other liabilities	272,774	273,767	257,832
Deferred tax liabilities	$ 209,330	$ 234,360	$ 217,189
Commitments and contingencies (Notes 2, 9, 10, and 11)
Stockholders’ deficit:
Preferred stock, $0.0001 par value: authorized: 50,000,000 shares; no shares issued and outstanding at October 31, 2015, January 31, 2015 and November 1, 2014
Common stock, $0.0001 par value: authorized: 500,000,000 shares at October 31, 2015, January 31, 2015 and November 1, 2014 Issued: 76,597,066 shares at October 31, 2015, 75,925,507 shares at January 31, 2015 and 75,241,724 shares at November 1, 2014 Outstanding: 73,560,207 shares at October 31, 2015, 75,254,682 shares at January 31, 2015 and 74,590,114 shares at November 1, 2014	$ 7	$ 7	$ 7
Additional paid-in-capital	1,391,034	1,370,498	1,361,603
Accumulated deficit	(1,374,745)	(1,426,454)	(1,521,319)
Accumulated other comprehensive loss	(5,844)	(1,744)	(745)
Treasury stock, at cost	(132,389)	(8,258)	(7,411)
Total stockholders' deficit	(121,937)	(65,951)	(167,865)
Total liabilities and stockholders' deficit	$ 2,805,317	$ 2,624,569	$ 2,796,901

Condensed Consolidated Balance3

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Oct. 31, 2015	Jan. 31, 2015	Nov. 01, 2014
Statement Of Financial Position [Abstract]
Preferred Stock, Par Value	$ 0.0001	$ 0.0001	$ 0.0001
Preferred Stock, Authorized	50,000,000	50,000,000	50,000,000
Preferred Stock, Issued	0	0	0
Preferred Stock, Outstanding	0	0	0
Common Stock, Par Value	$ 0.0001	$ 0.0001	$ 0.0001
Common Stock, Authorized	500,000,000	500,000,000	500,000,000
Common Stock, Shares Issued	76,597,066	75,925,507	75,241,724
Common Stock, Shares Outstanding	73,560,207	75,254,682	74,590,114

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2015	Nov. 01, 2014	Oct. 31, 2015	Nov. 01, 2014
REVENUES:
Net sales	$ 1,230,886	$ 1,157,292	$ 3,558,162	$ 3,329,142
Other revenue	7,783	8,816	22,998	23,950
Total revenue	1,238,669	1,166,108	3,581,160	3,353,092
COSTS AND EXPENSES:
Cost of sales	741,584	698,590	2,150,430	2,042,079
Selling, general and administrative expenses	416,205	396,713	1,175,491	1,093,760
Costs related to debt amendments, secondary offerings and other		589	247	1,930
Stock option modification expense	324	628	1,120	2,419
Depreciation and amortization	43,186	42,584	127,087	124,341
Impairment charges-long-lived assets		6	1,903	853
Other income—net	(1,680)	(1,705)	(4,142)	(5,569)
Loss on extinguishment of debt		70,302	649	73,983
Interest expense (inclusive of gain (loss) on interest rate cap agreements)	14,792	16,624	44,192	68,722
Total cost and expenses	1,214,411	1,224,331	3,496,977	3,402,518
Income (loss) before income tax expense (benefit)	24,258	(58,223)	84,183	(49,426)
Income tax expense (benefit)	9,142	(24,009)	32,474	(20,516)
Net income (loss)	$ 15,116	$ (34,214)	$ 51,709	$ (28,910)
Net income (loss) per common stock - basic	$ 0.20	$ (0.46)	$ 0.69	$ (0.39)
Net income (loss) per common stock - diluted	$ 0.20	$ (0.46)	$ 0.68	$ (0.39)
Weighted average number of common stock - basic	74,115	74,218	74,759	73,943
Weighted average number of common stock - diluted	75,394	74,218	76,135	73,943

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2015	Nov. 01, 2014	Oct. 31, 2015	Nov. 01, 2014
Statement Of Income And Comprehensive Income [Abstract]
Net income (loss)	$ 15,116	$ (34,214)	$ 51,709	$ (28,910)
Interest rate cap contracts:
Unrealized losses, net of related tax benefit of $2.2 million and $2.8 million for the three and nine months ended October 31,2015, respectively, and $0.5 million for the three and nine months ended November 1, 2014, respectively.	(3,358)	(745)	(4,179)	(745)
Amount reclassified into earnings, net of related taxes of less than $0.1 million and $0.1 million for the three and nine months ended October 31, 2015, respectively.	55		79
Other comprehensive (loss), net of tax:	(3,303)	(745)	(4,100)	(745)
Total comprehensive income (loss)	$ 11,813	$ (34,959)	$ 47,609	$ (29,655)

Condensed Consolidated Stateme6

Condensed Consolidated Statements of Comprehensive Income (Unaudited) (Parenthetical) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Oct. 31, 2015	Oct. 31, 2015
Unrealized losses on Interest Rate Cap Contracts, Tax Benefit	$ 2.2	$ 2.8
Amount reclassified into earnings on Interest Rate Cap Contracts, Tax		0.1
Maximum
Amount reclassified into earnings on Interest Rate Cap Contracts, Tax	$ 0.1	$ 0.1

Condensed Consolidated Stateme7

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands		9 Months Ended
		Oct. 31, 2015	Nov. 01, 2014
OPERATING ACTIVITIES
Net income (loss)		$ 51,709	$ (28,910)
Adjustments to reconcile net income (loss) to net cash provided by operating activities
Depreciation and amortization		127,087	124,341
Impairment charges-long-lived assets		1,903	853
Amortization of deferred financing costs		2,156	5,303
Accretion of long-term debt instruments		609	1,358
Deferred income tax (benefit)		(22,001)	(29,764)
Non-cash loss on extinguishment of debt—write-off of deferred financing costs and original issue discount		649	27,687
Non-cash stock compensation expense	[1]	8,237	4,616
Non-cash rent expense		(17,354)	(13,819)
Deferred rent incentives		18,481	21,673
Excess tax benefit from stock based compensation		(10,211)	(9,144)
Changes in assets and liabilities:
Accounts receivable		(7,430)	(19,967)
Merchandise inventories		(145,303)	(179,828)
Prepaid and other current assets		(13,008)	(40,372)
Accounts payable		82,505	223,523
Other current liabilities		21,094	(979)
Other long term assets and long term liabilities		3,251	1,282
Other		1,325	651
Net cash provided by operating activities		103,699	88,504
INVESTING ACTIVITIES
Cash paid for property and equipment		(153,720)	(164,525)
Proceeds from sale of property and equipment and assets held for sale		4,213	161
Net cash used in investing activities		(149,507)	(164,364)
FINANCING ACTIVITIES
Proceeds from long term debt—ABL Line of Credit		1,173,200	728,300
Principal payments on long term debt—ABL Line of Credit		(960,300)	(523,100)
Principal payments on long term debt—Holdco Notes			(128,223)
Principal payments on long term debt—Senior Notes			(450,000)
Cash payments for interest rate cap contracts			(4,478)
Proceeds from sale of interest rate cap contracts		1,169
Repayment of capital lease obligations		(779)	(737)
Purchase of treasury shares		(124,131)	(3,086)
Proceeds from stock option exercises		1,926	1,585
Excess tax benefit from stock based compensation		10,211	9,144
Deferred financing costs		(2,399)	(13,585)
Other		409
Net cash provided by (used in) financing activities		49,306	(27,687)
Increase (decrease) in cash and cash equivalents		3,498	(103,547)
Cash and cash equivalents at beginning of period		25,349
Cash and cash equivalents at end of period		28,847	29,437
Supplemental disclosure of cash flow information:
Interest paid		43,499	83,849
Income tax payments - net		54,264	72,670
Non-cash investing activities:
Accrued purchases of property and equipment		27,256	26,865
Acquisition of capital lease			5,621
Term B-3 Loans
FINANCING ACTIVITIES
Proceeds from long term debt—Term B-3 Loans			1,194,000
Principal payments on long term debt		$ (50,000)	(3,000)
Term B-2 Loans
FINANCING ACTIVITIES
Principal payments on long term debt			$ (834,507)
[1]	The amounts presented in the table above exclude taxes. For the three and nine month periods ended October 31, 2015, the tax benefit related to the Company’s non-cash stock compensation was approximately $1.1 million and $3.2 million, respectively. For the three and nine month periods ended November 1, 2014, the tax benefit related to the Company’s non-cash stock compensation was approximately $0.6 million and $1.9 million, respectively.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Oct. 31, 2015
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	1. Summary of Significant Accounting Policies Basis of Presentation As of October 31, 2015, Burlington Stores, Inc. and its subsidiaries (the Company), a Delaware Corporation, through its indirect subsidiary Burlington Coat Factory Warehouse Corporation (BCFWC), operated 566 retail stores, inclusive of an internet store. These unaudited Condensed Consolidated Financial Statements include the accounts of Burlington Stores, Inc. and its subsidiaries. All inter-company accounts and transactions have been eliminated in consolidation. The Condensed Consolidated Financial Statements are unaudited, but in the opinion of management reflect all adjustments (which are of a normal and recurring nature) necessary for the fair presentation of the results of operations for the interim periods presented. Certain information and note disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) have been condensed or omitted. It is suggested that these Condensed Consolidated Financial Statements be read in conjunction with the audited Consolidated Financial Statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended January 31, 2015 (Fiscal 2014 10-K). The balance sheet at January 31, 2015 presented herein has been derived from the audited Consolidated Financial Statements contained in the Fiscal 2014 10-K. Because the Company’s business is seasonal in nature, the operating results for the three and nine month periods ended October 31, 2015 are not necessarily indicative of results for the fiscal year ending January 30, 2016 (Fiscal 2015). Accounting policies followed by the Company are described in Note 1 to the Fiscal 2014 10-K, “Summary of Significant Accounting Policies.” In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2014-09, “Revenue from Contracts with Customers,” which provides guidance for revenue recognition. The standard’s core principle is that a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. In doing so, companies will need to use more judgment and make more estimates than under current guidance. These may include identifying performance obligations in the contract, estimating the amount of variable consideration included in the transaction price and allocating the transaction price to each separate performance obligation. At its July 9, 2015 meeting, the FASB affirmed its proposal to defer the effective date of this ASU for reporting periods beginning after December 15, 2017, with early adoption permitted for annual reporting periods beginning on or after December 15, 2016, and interim periods within those annual periods. The effective date of this ASU for the Company is February 4, 2018. The Company is currently in the process of evaluating the impact of adoption of this ASU on its Consolidated Financial Statements. In April 2015, the FASB issued ASU 2015-03, “Interest—Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs.” This standard amends existing guidance to require the presentation of debt issuance costs in the balance sheet as a deduction from the carrying amount of the related debt liability. This ASU is effective for fiscal years beginning after December 15, 2015, with early adoption permitted. The Company intends to adopt this ASU during the fiscal year beginning on January 31, 2016. The Company does not expect this standard to have a significant effect on its Consolidated Financial Statements. There were no other new accounting standards that had a material impact on the Company’s Condensed Consolidated Financial Statements during the three and nine month periods ended October 31, 2015, and there were no other new accounting standards or pronouncements that were issued but not yet effective as of October 31, 2015 that the Company expects to have a material impact on its financial position or results of operations upon becoming effective. Secondary Offering On April 7, 2015, the Company closed a secondary public offering of 12,490,154 shares of its common stock (the Secondary Offering). All of the shares sold in the Secondary Offering were offered by selling stockholders. The Company did not receive any of the proceeds from the Secondary Offering. The Company incurred $0.2 million in offering costs related to the Secondary Offering, which are included in the line item “Costs related to debt amendments, secondary offerings and other” on the Company’s Condensed Consolidated Statements of Operations.

Long Term Debt

Long Term Debt	9 Months Ended
	Oct. 31, 2015
Debt Disclosure [Abstract]
Long Term Debt	2. Long Term Debt Long term debt consists of: (in thousands) October 31, January 31, November 1, 2015 2015 2014 $1,200,000 senior secured term loan facility (Term B-3 Loans), LIBOR (with a floor of 1.0%) plus 3.25%, matures on August 13, 2021 $ 1,112,376 $ 1,161,541 $ 1,191,194 $600,000 ABL senior secured revolving facility, LIBOR plus spread based on average outstanding balance, matures August 13, 2019 276,200 63,300 205,200 Capital lease obligations 25,231 25,602 27,719 Total debt 1,413,807 1,250,443 1,424,113 Less: current maturities (1,376 ) (1,167 ) (13,275 ) Long term debt, net of current maturities $ 1,412,431 $ 1,249,276 $ 1,410,838 Term Loan Facility On August 13, 2014, BCFWC entered into Amendment No. 4 (the Fourth Amendment) to the Term Loan Credit Agreement (as amended by the Fourth Amendment, the Amended Term Loan Credit Agreement) governing its senior secured term loan facility (the Term Loan Facility). The Fourth Amendment, among other things, (i) increased the available incremental amount to $400.0 million plus unlimited amounts so long as BCFWC’s pro forma consolidated secured leverage ratio does not exceed 3.50 to 1.00 and (ii) gave BCFWC and its restricted subsidiaries additional flexibility to make investments, restricted payments (including dividends), incur additional debt, grant liens and otherwise comply with its covenants under the Amended Term Loan Credit Agreement. The interest rate margin applicable under the Amended Term Loan Credit Agreement is 3.25% in the case of loans drawn at LIBOR and 2.25% in the case of loans drawn under the prime rate (as determined by the Term Loan Facility Administrative Agent). The Fourth Amendment removed the variable pricing mechanism that was formerly in place, which was based on BCFWC’s pro forma consolidated secured leverage ratio. The Term Loan Facility is collateralized by a first lien on our favorable leases, real estate and property & equipment and a second lien on our inventory and receivables. The Term B-3 Loans outstanding under the Term Loan Facility mature on August 13, 2021. Mandatory quarterly payments of $3.0 million were payable as of the last day of each quarter, beginning with the quarter ended July 29, 2017. The Company elected to make a prepayment of $50.0 million on May 1, 2015, which offset the mandatory quarterly payments through May 1, 2021. In accordance with ASC Topic No. 470-50, “Debt Modifications and Extinguishments” (Topic No. 470), the Company recognized a non-cash loss on the partial extinguishment of debt of $0.6 million, representing the write-off of $0.4 million and $0.2 million in deferred financing costs and unamortized original issue discount, respectively, which was recorded in the line item “Loss on extinguishment of debt” in the Company’s Condensed Consolidated Statements of Operations. Interest rates for the Term Loan Facility are based on: (i) for LIBOR rate loans for any interest period, at a rate per annum equal to the greater of (x) the LIBOR rate, as determined by the Term Loan Facility Administrative Agent, for such interest period multiplied by the Statutory Reserve Rate (as defined in the Term Loan Credit Agreement) and (y) 1.00% (the Term Loan Adjusted LIBOR Rate), plus an applicable margin; and (ii) for prime rate loans, a rate per annum equal to the highest of (a) the variable annual rate of interest then announced by JPMorgan Chase Bank, N.A. at its head office as its “prime rate,” (b) the federal funds rate in effect on such date plus 0.50% per annum, and (c) the Term Loan Adjusted LIBOR Rate for the applicable class of term loans for one-month plus 1.00%, plus, in each case, an applicable margin. At October 31, 2015, the Company’s borrowing rate related to the Term Loan Facility was 4.25%. ABL Line of Credit On August 13, 2014, BCFWC also entered into Amendment No. 1 (the ABL Amendment) to the Second Amended and Restated Credit Agreement, dated September 2, 2011 (as amended, supplemented and otherwise modified, the Amended ABL Credit Agreement) governing BCFWC’s existing senior secured asset-based revolving credit facility (the ABL Line of Credit). The ABL Amendment, among other things, provided BCFWC and certain of its subsidiaries with additional flexibility to make investments, restricted payments (including dividends), incur additional debt, grant liens and otherwise comply with its covenants under the Amended ABL Credit Agreement. The Company believes that the Amended ABL Credit Agreement provides the liquidity and flexibility to meet its operating and capital requirements over the remaining term of the ABL Line of Credit. Further, the calculation of the borrowing base under the amended and restated credit agreement has been amended to allow for increased availability, particularly during the September 1st through December 15th period of each year. The ABL Line of Credit matures on August 13, 2019. The aggregate amount of commitments under the Amended ABL Credit Agreement is $600.0 million and, subject to the satisfaction of certain conditions, the Company can increase the aggregate amount of commitments up to $900.0 million. Interest rate margin applicable under the Amended ABL Credit Agreement in the case of loans drawn at LIBOR is 1.25% - 1.50% (based on total commitments or borrowing base availability), and the fee on the average daily balance of unused loan commitments is 0.25%. The ABL Line of Credit is collateralized by a first lien on the Company’s inventory and receivables and a second lien on the Company’s real estate and property and equipment. At October 31, 2015, the Company had $278.2 million available under the Amended ABL Line of Credit and $276.2 million of outstanding borrowings. The maximum borrowings under the facility during the three and nine month periods ended October 31, 2015 amounted to $330.7 million. Average borrowings during the three and nine month periods ended October 31, 2015 amounted to $270.2 million and $199.7 million, respectively, at average interest rates of 1.6%. The Company had outstanding borrowings under the Amended ABL Line of Credit of $63.3 million as of January 31, 2015. At November 1, 2014, the Company had $346.3 million available under the ABL Line of Credit and $205.2 million of outstanding borrowings. The maximum borrowings under the facility during the three and nine month periods ended November 1, 2014 amounted to $297.0 million. Average borrowings during the three and nine month periods ended November 1, 2014 amounted to $226.5 million and $83.8 million, respectively at average interest rates of 1.7%.

Derivative Instruments and Hedg

Derivative Instruments and Hedging Activities	9 Months Ended
	Oct. 31, 2015
Derivative Instruments And Hedging Activities Disclosure [Abstract]
Derivative Instruments and Hedging Activities	3. Derivative Instruments and Hedging Activities The Company accounts for derivatives and hedging activities in accordance with ASC Topic No. 815 “Derivatives and Hedging” (Topic No. 815). Topic No. 815 provides the disclosure requirements for derivatives and hedging activities with the intent to provide users of financial statements with an enhanced understanding of: (i) how and why an entity uses derivative instruments, (ii) how the entity accounts for derivative instruments and related hedged items, and (iii) how derivative instruments and related hedged items affect an entity’s financial position, financial performance, and cash flows. Further, qualitative disclosures are required that explain the Company’s objectives and strategies for using derivatives, as well as quantitative disclosures about the fair value of gains and losses on derivative instruments, and disclosures about credit-risk-related contingent features in derivative instruments. As required by Topic No. 815, the Company records all derivatives on the balance sheet at fair value and adjusts to market on a quarterly basis. The accounting for changes in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative in a hedging relationship and apply hedge accounting and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. Derivatives designated and qualifying as a hedge of the exposure to variability in expected future cash flows, or other types of forecasted transactions, are considered cash flow hedges. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the earnings effect of the hedged forecasted transactions in a cash flow hedge. The Company may enter into derivative contracts that are intended to economically hedge certain of its risk, even though hedge accounting does not apply or the Company elects not to apply hedge accounting. The Company uses interest rate cap contracts to manage interest rate risk. The fair value of the Company’s interest rate cap contracts is determined using the market standard methodology of discounted future variable cash flows. The variable cash flows are determined using the market standard methodology of discounting the future expected cash receipts that would occur if variable interest rates rise above the strike rate of the caps in conjunction with the cash payments related to financing the premium of the interest rate caps. The variable interest rates used in the calculation of projected receipts on the cap are based on an expectation of future interest rates derived from observable market interest rate curves and volatilities. In addition, to comply with the provisions of ASC Topic No. 820, “Fair Value Measurements” (Topic No. 820), credit valuation adjustments, which consider the impact of any credit enhancements to the contracts, are incorporated in the fair values to account for potential nonperformance risk. In adjusting the fair value of its derivative contracts for the effect of nonperformance risk, the Company has considered any applicable credit enhancements such as collateral postings, thresholds, mutual puts, and guarantees. In accordance with Topic No. 820, the Company made an accounting policy election to measure the credit risk of its derivative financial instruments that are subject to master netting agreements on a net basis by counterparty portfolio. There is no impact of netting because the Company’s only derivatives are interest rate cap contracts that are with separate counterparties and are under separate master netting agreements. Although the Company has determined that the majority of the inputs used to value its derivatives fall within Level 2 of the fair value hierarchy, the credit valuation adjustments associated with its derivatives utilize Level 3 inputs, such as estimates of current credit spreads to evaluate the likelihood of default by the Company and its counterparties. However, as of October 31, 2015, January 31, 2015 and November 1, 2014, the Company has assessed the significance of the impact of the credit valuation adjustments on the overall valuation of its derivative positions and has determined that the credit valuation adjustment is not significant to the overall valuation of its derivative portfolios. As a result, the Company classifies its derivative valuations in Level 2 of the fair value hierarchy. The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest rate, liquidity, and credit risk primarily by managing the amount, sources, and duration of its debt funding and the use of derivative financial instruments. Specifically, the Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the payment of future known and uncertain cash amounts, the value of which are determined by interest rates. The Company’s derivative financial instruments are used to manage differences in the amount, timing, and duration of the Company’s known or expected cash payments principally related to the Company’s borrowings. Cash Flow Hedges of Interest Rate Risk The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate caps as part of its interest rate risk management strategy. Interest rate caps designated as cash flow hedges involve the receipt of variable amounts from a counterparty if interest rates rise above the strike rate on the contract. On August 19, 2014, the Company entered into four interest rate cap contracts which were designated as cash flow hedges (the Previous Interest Rate Cap Contracts). On April 24, 2015, the Company terminated and sold the Previous Interest Rate Cap Contracts. The Company received $1.2 million in cash in connection with the termination and sale of the Previous Interest Rate Cap Contracts. As a result of these transactions, the amount of loss previously deferred in accumulated other comprehensive loss related to these caps was $2.0 million, net of taxes of $1.3 million. The Company will amortize this loss from accumulated other comprehensive loss into interest expense over the original life of each respective cap through April 2019. Also on April 24, 2015, the Company entered into two new interest rate cap contracts (the New Interest Rate Cap Contracts) which were designated as cash flow hedges. The Company financed the cost of the New Interest Rate Cap Contracts, which will be amortized through the life of the caps. Through the nine month period ended October 31, 2015, the Company paid $2.2 million related to the financing of the New Interest Rate Cap Contracts, which is included in the line item “Deferred financing costs” in the Company’s Condensed Consolidated Statements of Cash Flows. During the nine month period ended October 31, 2015, such derivatives were used to hedge the variable cash flows associated with existing (or anticipated) variable-rate debt. The effective portion of changes in the fair value of derivatives designated and that qualify as cash flow hedges is recorded in the line item “Accumulated other comprehensive loss” on the Company’s Condensed Consolidated Balance Sheets and is subsequently reclassified into earnings in the period that the hedged forecasted transaction affects earnings. Amounts reported in accumulated other comprehensive loss related to the New Interest Rate Cap Contracts will be reclassified to interest expense as interest payments are made on the Company’s variable-rate debt. During the three and nine month periods ended October 31, 2015, the Company reclassified $0.1 million out of accumulated other comprehensive loss into interest expense. As of October 31, 2015, the Company estimates that approximately $1.6 million will be reclassified into interest expense during the next twelve months. The ineffective portion of the change in fair value of the derivatives is recognized directly in earnings. The Company did not record any hedge ineffectiveness in its earnings during the three or nine month periods ended October 31, 2015. As of October 31, 2015, the Company had the following outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk: Interest Rate Derivative Number of Instruments Notional Aggregate Principal Amount Interest Cap Rate Effective Date Maturity Date Interest rate cap contracts Two $ 800.0 million 1.0% May 29, 2015 May 31, 2019 Derivatives not designated as hedges are not speculative and are used to manage the Company’s exposure to interest rate movements and other identified risks but do not meet the strict hedge accounting requirements or the Company elected not to designate these derivatives as hedges. Changes in the fair value of derivatives not designated in hedging relationships are recorded directly in earnings. The Company had two interest rate cap contracts which limited our interest rate exposure to 7.0% on our first $900.0 million of borrowings under our variable rate debt obligations that expired on May 31, 2015. As of October 31, 2015, the Company no longer has any outstanding derivatives that were not designated as hedges in qualifying hedging relationships. Tabular Disclosure The tables below present the fair value of the Company’s derivative financial instruments on a gross basis as well as their classification on the Company’s Condensed Consolidated Balance Sheets: (in thousands) Fair Values of Derivative Instruments Asset Derivatives October 31, 2015 January 31, 2015 November 1, 2014 Derivatives Designated as Hedging Instruments Balance Sheet Location Fair Value Balance Sheet Location Fair Value Balance Sheet Location Fair Value Interest rate cap contracts N/A $ — Other assets $ 1,572 Other assets $ 3,237 (in thousands) Fair Values of Derivative Instruments Liability Derivatives October 31, 2015 January 31, 2015 November 1, 2014 Derivatives Designated as Hedging Instruments Balance Sheet Location Fair Value Balance Sheet Location Fair Value Balance Sheet Location Fair Value Interest rate cap contracts Other $ 4,331 N/A $ — N/A $ — The tables below present the amounts of losses recognized in other comprehensive loss, net of taxes, and the classification of losses reclassified into earnings related to the Company’s derivative instruments designated as cash flow hedging instruments for each of the reporting periods. (in thousands) Amount of Losses Recognized in Other Comprehensive Loss Related to Derivatives Derivatives Designated as Three Months Ended Nine Months Ended Hedging Instruments October 31, 2015 November 1, 2014 October 31, 2015 November 1, 2014 Interest rate cap contracts $ (3,358 ) $ (745 ) $ (4,179 ) $ (745 ) (in thousands) Amount of Loss Reclassified from Accumulated Other Comprehensive Loss into Earnings Related to Derivatives Derivatives Designated as Three Months Ended Nine Months Ended Component of Hedging Instruments October 31, 2015 November 1, 2014 October 31, 2015 November 1, 2014 Earnings Interest rate cap contracts $ 55 $ — $ 79 $ — Interest The table below presents the classification of losses recognized within our statements of operations for the Company’s derivative instruments not designated as hedging instruments for each of the reporting periods. (in thousands) Amount of Loss Recognized in Earnings Location of Loss Recognized in Earnings Three Months Ended Nine Months Ended Derivatives Not Designated as Hedging Instruments Related to Derivatives October 31, 2015 November 1, 2014 October 31, 2015 November 1, 2014 Interest rate cap contracts Interest expense $ — $ — $ — $ 1

Accumulated Other Comprehensive

Accumulated Other Comprehensive Loss	9 Months Ended
	Oct. 31, 2015
Equity [Abstract]
Accumulated Other Comprehensive Loss	4. Accumulated Other Comprehensive Loss Amounts included in accumulated other comprehensive loss are recorded net of the related income tax effects. The following table details the changes in accumulated other comprehensive loss: (in thousands) Derivative Instruments Total Balance at January 31, 2015 $ (1,744 ) $ (1,744 ) Unrealized losses arising during the period, net of related tax benefit of $2.8 million for the nine months ended October 31, 2015 (4,179 ) (4,179 ) Amount reclassified into earnings, net of related taxes of $0.1 million for the nine months ended October 31, 2015 79 79 Balance at October 31, 2015 $ (5,844 ) $ (5,844 )

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Oct. 31, 2015
Fair Value Disclosures [Abstract]
Fair Value Measurements	5. Fair Value Measurements The Company accounts for fair value measurements in accordance with Topic No. 820, which defines fair value, establishes a framework for measurement and expands disclosure about fair value measurements. Topic No. 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price), and classifies the inputs used to measure fair value into the following hierarchy: Level 1: Quoted prices for identical assets or liabilities in active markets. Level 2: Quoted market prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable. Level 3: Pricing inputs that are unobservable for the assets and liabilities and include situations where there is little, if any, market activity for the assets and liabilities. The inputs into the determination of fair value require significant management judgment or estimation. The carrying amounts of cash equivalents, accounts receivable and accounts payable approximate fair value due to the short-term nature of these instruments. Refer to Note 3, “Derivative Instruments and Hedging Activities,” for further discussion regarding the fair value of the Company’s interest rate cap contracts. Financial Assets The fair values of the Company’s financial assets and the hierarchy of the level of inputs as of October 31, 2015, January 31, 2015 and November 1, 2014 are summarized below: (in thousands) Fair Value Measurements at October 31, January 31, November 1, 2015 2015 2014 Assets: Level 1 Cash equivalents (including restricted cash) $ 28,109 $ 28,094 $ 32,349 Long-Lived Assets Long-lived assets are measured at fair value on a non-recurring basis for purposes of calculating impairment using the fair value hierarchy of Topic No. 820. The fair value of the Company’s long-lived assets is generally calculated using discounted cash flows. During the nine month period ended October 31, 2015, the Company recorded impairment charges of $1.7 million, primarily related to declines in revenues and operating results for two stores, which was recorded in the line item “Impairment charges – long-lived assets” in the Company’s Condensed Consolidated Statements of Operations. During the nine month period ended October 31, 2015, the Company also recorded impairment charges for capital expenditures for previously impaired stores of approximately $0.2 million. One of the stores impaired during the nine month period ended October 31, 2015 was fully impaired and therefore had zero fair value as of October 31, 2015, and would be categorized as Level 3 in the fair value hierarchy described above. The table below sets forth, by level within the fair value hierarchy, the fair value of the remaining, partially-impaired store, subsequent to impairment charges as of October 31, 2015: (in thousands) Quoted in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Un- Observable Inputs (Level 3) Total Total Impairment Losses Leasehold improvements $ — $ — $ 388 $ 388 $ 766 Building/Building Improvements — — — — 12 Furniture and fixtures — — 341 341 645 Other assets — — 237 237 320 Other property and equipment — — 19 19 160 Total $ — $ — $ 985 $ 985 $ 1,903 Financial Liabilities The fair values of the Company’s financial liabilities are summarized below: (in thousands) October 31, 2015 January 31, 2015 November 1, 2014 Carrying Amount (b) Fair Value (b) Carrying Amount (b) Fair Value (b) Carrying Amount (b) Fair Value (b) $1,200,000 senior secured term loan facility (Term B-3 Loans), LIBOR (with a floor of 1.0%) plus 3.25%, matures on August 13, 2021 $ 1,112,376 $ 1,114,210 $ 1,161,541 $ 1,150,410 $ 1,191,194 $ 1,185,715 $600,000 ABL senior secured revolving facility, LIBOR plus spread based on average outstanding balance, expires August 13, 2019(a) 276,200 276,200 63,300 63,300 205,200 205,200 Total debt $ 1,388,576 $ 1,390,410 $ 1,224,841 $ 1,213,710 $ 1,396,394 $ 1,390,915 (a) To the extent the Company has any outstanding borrowings under the ABL Line of Credit, the fair value would approximate its reported value because the interest rate is variable and reflects current market rates due to its short term nature (borrowings are typically done in 30 day increments). (b) Capital lease obligations are excluded from the table above. The fair values presented herein are based on pertinent information available to management as of the respective period end dates. The estimated fair values of the Company’s debt are classified as Level 2 in the fair value hierarchy. Although management is not aware of any factors that could significantly affect the estimated fair value amounts, such amounts have not been comprehensively revalued for purposes of these Condensed Consolidated Financial Statements since October 31, 2015, and current estimates of fair value may differ from amounts presented herein.

Income Taxes

Income Taxes	9 Months Ended
	Oct. 31, 2015
Income Tax Disclosure [Abstract]
Income Taxes	6. Income Taxes Net deferred taxes are as follows: (in thousands) October 31, January 31, November 1, 2015 2015 2014 Current deferred tax asset $ 36,934 $ 37,229 $ 18,216 Non-current deferred tax liability 209,330 234,360 217,189 Net deferred tax liability $ 172,396 $ 197,131 $ 198,973 Current deferred tax assets consisted primarily of certain operating costs and inventory-related costs not currently deductible for tax purposes. Non-current deferred tax liabilities primarily relate to rent expense, intangible assets, and depreciation expense where the Company has a future obligation for tax purposes. As of October 31, 2015, January 31, 2015 and November 1, 2014, valuation allowances amounted to $6.2 million, $6.1 million and $5.7 million, respectively, primarily related to state tax net operating losses and state tax credit carry forwards. The Company believes that it is more likely than not that a portion of the benefit of the state tax net operating losses will not be realized. As of October 31, 2015, the Company had $7.4 million of deferred tax assets recorded for state net operating losses of which $5.6 million will expire between 2015 and 2025. In addition, management also determined that a full valuation allowance of $5.4 million, $4.5 million and $3.8 million were required against the tax benefit associated with Puerto Rico deferred tax assets as of October 31, 2015, January 31, 2015 and November 1, 2014, respectively.

Capital Stock

Capital Stock	9 Months Ended
	Oct. 31, 2015
Capital Stock [Abstract]
Capital Stock	7. Capital Stock Treasury Stock The Company accounts for treasury stock under the cost method. During the nine month period ended October 31, 2015, the Company acquired 23,620 shares of common stock from employees for $1.2 million to satisfy their minimum statutory tax withholdings related to the vesting of restricted stock awards. These shares are considered treasury shares which are available for reissuance under the 2006 Management Incentive Plan. Share Repurchase Programs On June 9, 2015, the Company announced that its Board of Directors had authorized the repurchase of up to $200 million of its common stock. The repurchase program will be funded using the Company’s available cash and is authorized to be executed through June 2017. During the nine month period ended October 31, 2015, the Company repurchased 2,342,414 shares of its common stock for $123.0 million, inclusive of commissions, under this share repurchase program, which was recorded in the line item “Treasury stock” on the Company’s Condensed Consolidated Balance Sheet. As of October 31, 2015, the Company had $77.0 million available for purchase under this share repurchase program. On November 24, 2015, the Company announced that its Board of Directors had authorized the repurchase of up to an additional $200 million of its common stock. This repurchase program will be funded using the Company’s available cash and is authorized to be executed through November 2017. Refer to Note 13, “Subsequent Events,” for further discussion.

Net Income (Loss) Per Share

Net Income (Loss) Per Share	9 Months Ended
	Oct. 31, 2015
Earnings Per Share [Abstract]
Net Income (Loss) Per Share	8. Net Income (Loss) Per Share Basic net income (loss) per share is calculated by dividing net income (loss) by the weighted-average common shares outstanding. Dilutive net income (loss) per share is calculated by dividing net income (loss) by the weighted-average common shares and potentially dilutive securities outstanding during the period using the treasury stock method. (in thousands, except per share data) Three Months Ended Nine Months Ended October 31, November 1, October 31, November 1, 2015 2014 2015 2014 Basic net income (loss) per share Net income (loss) $ 15,116 $ (34,214 ) $ 51,709 $ (28,910 ) Weighted average number of common shares – basic 74,115 74,218 74,759 73,943 Net income (loss) per common share – basic $ 0.20 $ (0.46 ) $ 0.69 $ (0.39 ) Diluted net income (loss) per share Net income (loss) $ 15,116 $ (34,214 ) $ 51,709 $ (28,910 ) Shares for basic and diluted net income (loss) per share: Weighted average number of common shares – basic 74,115 74,218 74,759 73,943 Assumed exercise of stock options and vesting of restricted stock 1,279 — 1,376 — Weighted average number of common shares – diluted 75,394 74,218 76,135 73,943 Net income (loss) per common share – diluted $ 0.20 $ (0.46 ) $ 0.68 $ (0.39 ) Approximately 150,000 and less than 100,000 options to purchase shares of common stock and unvested restricted stock awards were excluded from diluted net income (loss) per share for the three and nine month periods ended October 31, 2015, respectively, since their effect was anti-dilutive. As of November 1, 2014, there were 3,777,194 outstanding options to purchase shares of common stock and 163,278 shares of unvested restricted stock awards that were excluded from diluted earnings per share since their effect was anti-dilutive.

Stock Option and Award Plans an

Stock Option and Award Plans and Stock-Based Compensation	9 Months Ended
	Oct. 31, 2015
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Stock Option and Award Plans and Stock-Based Compensation	9. Stock Option and Award Plans and Stock-Based Compensation As of October 31, 2015, there were 10,125,258 shares of common stock authorized for issuance under the 2006 Management Incentive Plan (the 2006 Plan) and 6,000,000 shares of common stock authorized for issuance under the 2013 Omnibus Incentive Plan (the 2013 Plan and, together with the 2006 Plan, the Plans). Stock Options The Company accounts for awards issued under the Plans in accordance with ASC Topic No. 718, “ ” In order to mitigate the impact of the $336.0 million dividend paid in connection with the issuance of the $350.0 million aggregate principal amount of Senior Notes (Holdco Notes) in February 2013, the Company’s Board of Directors in May 2013 approved a modification to all then outstanding options through a combination of exercise price reductions and cash payments to option holders. The modification did not affect the existing vesting schedules. The Company recorded $0.3 million and $1.1 million of incremental compensation expense during the three and nine month periods ended October 31, 2015, respectively, of which less than $0.1 million and $0.2 million, respectively, will be paid in cash. The Company recorded $0.6 million and $2.4 million of incremental compensation expense during the three and nine month periods ended November 1, 2014, respectively, of which $0.1 million and $0.5 million, respectively, was paid in cash. These costs were recorded in the line item “Stock option modification expense” in the Company’s Condensed Consolidated Statements of Operations. As of October 31, 2015, the Company expects to recognize $1.0 million of incremental compensation expense to be recorded over the remaining vesting periods through the fiscal year ended February 3, 2018, of which $0.1 million will be paid in cash. During the second quarter of Fiscal 2013, the Company made a special one-time grant of options to purchase shares of common stock under the 2006 Plan to certain members of its management team. These one-time grants vest 20% on each of the first five anniversaries of the Trigger Date. The Trigger Date is defined as the date after the vesting of all other options held by the grantee which were granted to the grantee prior to May 2013 and remain outstanding and unvested as of the date of the one-time grant. With the exception of the special one-time grants made during Fiscal 2013, all options awarded pursuant to the 2006 Plan become exercisable upon a change of control. The vesting of special one-time grants will not be accelerated in the event of a change of control, provided, however, that in the event that within two years after a change of control, the grantee’s employment is terminated without cause or the grantee resigns with good reason, then an incremental 20% of the special one-time grants shall be deemed vested as of the date of termination of grantee’s employment, but in no event more than the total number of special one-time grants granted to such grantee. Unless determined otherwise by the plan administrator, upon cessation of employment, the majority of options that have not vested will terminate immediately (subject to the potential acceleration of special one-time grants in the event of a change of control, as described above) and unexercised vested options will be exercisable for a period of 60 days. The final exercise date for any option granted is the tenth anniversary of the grant date. Non-cash stock compensation expense is as follows: (in thousands) Three Months Ended Nine Months Ended October 31, November 1, October 31, November 1, Type of Non-Cash Stock Compensation 2015 2014 2015 2014 Restricted stock grants (a) $ 1,623 $ 247 $ 4,574 $ 528 Stock option grants (a) 1,099 730 2,764 2,201 Stock option modification (b) 257 487 899 1,887 Total (c) $ 2,979 $ 1,464 $ 8,237 $ 4,616 (a) Included in the line item “Selling, general and administrative expenses” in the Company’s Condensed Consolidated Statements of Operations. (b) Represents non-cash compensation related to the May 2013 stock option modification as discussed above. Amounts are included in the line item “Stock option modification expense” in the Company’s Condensed Consolidated Statements of Operations. (c) The amounts presented in the table above exclude taxes. For the three and nine month periods ended October 31, 2015, the tax benefit related to the Company’s non-cash stock compensation was approximately $1.1 million and $3.2 million, respectively. For the three and nine month periods ended November 1, 2014, the tax benefit related to the Company’s non-cash stock compensation was approximately $0.6 million and $1.9 million, respectively. As of October 31, 2015, the Company had 2,829,551 options outstanding to purchase shares of common stock, all of which are service-based awards issued under the 2006 Plan. As of October 31, 2015, no options were outstanding under the 2013 Plan. Stock option transactions during the nine month period ended October 31, 2015 are summarized as follows: Number of Shares Weighted Average Exercise Price Per Share Options outstanding, January 31, 2015 3,218,845 $ 4.93 Options granted 411,060 52.31 Options exercised (a) (538,043 ) 3.58 Options forfeited (262,311 ) 4.30 Options outstanding, October 31, 2015 2,829,551 $ 12.12 (a) Options exercised during the nine month period ended October 31, 2015 had a total intrinsic value of $28.2 million. The following table summarizes information about the stock options vested and expected to vest during the contractual term as of October 31, 2015: Options Weighted Average Remaining Contractual Life (Years) Weighted Average Exercise Price Aggregate Intrinsic Value Vested and expected to vest 2,475,965 7.43 $ 11.87 $ 91.1 million The fair value of each stock option granted during the nine month period ended October 31, 2015 was estimated using the Black Scholes option pricing model using the following assumptions: Nine Months Ended October 31, 2015 Risk-fee interest rate 1.81% Expected volatility 36.0% Expected life (years) 6.25 Contractual life (years) 10.0 Expected dividend yield 0.0% Weighted average grant date fair value of options issued $ 19.99 The expected dividend yield was based on the Company’s expectation of not paying dividends in the foreseeable future. Since the Company completed its initial public offering in October 2013, it does not have sufficient history as a publicly traded company to evaluate its volatility factor. As such, the expected stock price volatility is based upon the historical volatility of the stock price over the expected life of the options of peer companies that are publicly traded. The risk free interest rate was based on the U.S. Treasury rates for U.S. Treasury zero-coupon bonds with maturities similar to those of the expected term of the awards being valued. For grants issued during the nine month period ended October 31, 2015 and November 1, 2014, the expected life of the options was calculated using the simplified method. The simplified method defines the life as the average of the contractual term of the options and the weighted average vesting period for all option tranches. This methodology was utilized due to the short length of time our common stock has been publicly traded. Restricted Stock Awards Under the 2006 Plan, the Company also has the ability to grant shares of restricted stock. All shares of restricted stock granted to date under the 2006 Plan are service-based awards that cliff vest at the end of the requisite service period that typically ranges from three to four years. Following a change of control, all unvested shares of restricted stock shall remain unvested, provided, however, that 100% of such shares shall vest if, following such change of control, the employment of the recipient is terminated without cause or the recipient resigns with good reason. Restricted stock transactions during the nine month period ended October 31, 2015 are summarized as follows: Number of Shares Weighted Average Grant Date Fair Value Per Awards Non-vested awards outstanding, January 31, 2015 392,178 $ 38.56 Awards granted 172,276 52.07 Awards vested (62,683 ) 40.76 Awards forfeited (38,760 ) 13.81 Non-vested awards outstanding, October 31, 2015 463,011 $ 45.36 The fair value of each share of restricted stock granted during the nine month period ended October 31, 2015 was based upon the closing price of the Company’s common stock on the date of grant.

Other Liabilities

Other Liabilities	9 Months Ended
	Oct. 31, 2015
Other Liabilities Disclosure [Abstract]
Other Liabilities	10. Other Liabilities Other liabilities primarily consist of deferred lease incentives, the long term portion of self-insurance reserves, the excess of straight-line rent expense over actual rental payments and tax liabilities associated with the uncertain tax positions recognized by the Company in accordance with Topic No. 740. Deferred lease incentives are funds received or receivable from landlords used primarily to offset costs incurred for leasehold improvements and fixturing of new and remodeled stores. These deferred lease incentives are amortized over the expected lease term including rent holiday periods and option periods where the exercise of the option can be reasonably assured. Amortization of deferred lease incentives is included in the line item “Selling, general and administrative expenses” on the Company’s Condensed Consolidated Statements of Operations. At October 31, 2015, January 31, 2015 and November 1, 2014, deferred lease incentives were $165.7 million, $176.3 million and $158.8 million, respectively, and are recorded in the line item “Other Liabilities” on the Company’s Condensed Consolidated Balance Sheets.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Oct. 31, 2015
Commitments And Contingencies Disclosure [Abstract]
Commitments and Contingencies	11. Commitments and Contingencies Legal The Company establishes accruals relating to legal claims, in connection with litigation to which the Company is party from time to time in the ordinary course of business. Like many retailers, the Company has been named in class or collective actions on behalf of various groups alleging violations of federal and state wage and hour and other labor statutes, and alleged violation of state consumer and/or privacy protection statutes. In the normal course of business, we are also party to various other lawsuits and regulatory proceedings including, among others, commercial, product, product safety, employee, customer, intellectual property and other claims. Actions against us are in various procedural stages. Many of these proceedings raise factual and legal issues and are subject to uncertainties. To determine the likelihood of a loss and/or the measurement of any loss can be complex. Consequently, we are unable to estimate the range of reasonably possible loss in excess of amounts accrued. Our assessments are based on estimates and assumptions that have been deemed reasonable by management, but the assessment process relies heavily on estimates and assumptions that may prove to be incomplete or inaccurate, and unanticipated events and circumstances may occur that might cause us to change those estimates and assumptions. The ultimate outcome of these cases could have a material adverse effect on the Company’s results of operations. In the matter of Burlington Coat Factory Song Beverly Cases In October 2015, the Company entered into a settlement agreement providing for a maximum settlement payment of $29.4 million (including attorneys’ fees and claims administration fees). On November 6, 2015, the court granted preliminary approval for the settlement and authorized the parties to provide a notice to class members about the settlement. The notice period is currently under way. Because of the claims-made aspect of the settlement, it is likely that a significant portion of the total settlement amount will go unclaimed and remain the property of the Company, thereby causing it to pay less than $29.4 million under the settlement. There have been no changes to the Company’s accrual related to this matter during the quarter ended October 31, 2015. This settlement, if it is approved by the Court, will result in the dismissal of all Song-Beverly claims that arose through January 28, 2015 (except for those class members who opt out of the settlement). If this settlement is rejected by the Court, the parties will likely return to the litigation of both lawsuits, and, in such event, the Company cannot predict the outcome of these matters, and cannot predict whether or not the outcome will have a material adverse effect on the Company’s financial condition or results of operations. Lease Agreements The Company enters into lease agreements during the ordinary course of business in order to secure favorable store locations. The Company’s minimum lease payments for all operating leases are expected to be $73.7 million for the remainder of Fiscal 2015 and $305.0 million, $298.2 million, $273.9 million, $229.0 million and $1,072.2 million for the fiscal years ended January 28, 2017, February 3, 2018, February 2, 2019, February 1, 2020 and all subsequent years thereafter, respectively. Total future minimum lease payments include $105.3 million related to options to extend lease terms that are reasonably assured of being exercised and also includes $236.8 million of minimum lease payments for 16 stores that the Company has committed to open or relocate. Letters of Credit The Company had letters of credit arrangements with various banks in the aggregate amount of $45.6 million, $48.1 million and $48.5 million as of October 31, 2015, January 31, 2015 and November 1, 2014, respectively. Among these arrangements as of October 31, 2015, January 31, 2015 and November 1, 2014, the Company had letters of credit in the amount of $35.3 million, $33.4 million and $34.4 million, respectively, guaranteeing performance under various insurance contracts and utility agreements. In addition, the Company had outstanding letters of credit agreements in the amounts of $10.3 million, $14.7 million and $14.1 million at October 31, 2015, January 31, 2015 and November 1, 2014, respectively, related to certain merchandising agreements. Based on the terms of the credit agreement related to the ABL Line of Credit, the Company had the ability to enter into letters of credit up to $278.2 million, $386.9 million and $346.3 million as of October 31, 2015, January 31, 2015 and November 1, 2014, respectively. Purchase Commitments The Company had $643.8 million of purchase commitments related to goods that were not received as of October 31, 2015. Death Benefits In November of 2005, the Company entered into agreements with three of the Company’s former executives whereby upon each of their deaths the Company will pay $1.0 million to each respective designated beneficiary.

Related Parties

Related Parties	9 Months Ended
	Oct. 31, 2015
Related Party Transactions [Abstract]
Related Parties	12. Related Parties The brother-in-law of one of the Company’s Executive Vice Presidents is an independent sales representative of one of the Company’s suppliers of merchandise inventory. This relationship predated the commencement of the Executive Vice President’s employment with the Company. The Company has determined that the dollar amount of purchases through such supplier represents an insignificant amount of its inventory purchases.

Subsequent Events

Subsequent Events	9 Months Ended
	Oct. 31, 2015
Subsequent Events [Abstract]
Subsequent Events	13. Subsequent Events On November 24, 2015, the Company announced that its Board of Directors had approved the repurchase of up to an additional $200 million of the Company’s common stock. This repurchase program, which is in addition to the share repurchase program announced by the Company in June 2015, will be funded using the Company’s available cash and is authorized to be executed through November 2017. The Company is authorized to repurchase from time to time shares of its outstanding common stock on the open market or in privately negotiated transactions under its repurchase programs. The timing and amount of stock repurchases will depend on a variety of factors, including the market conditions as well as corporate and regulatory considerations. The share repurchase programs may be suspended, modified or discontinued at any time and the Company has no obligation to repurchase any amount of the Company’s common stock under the programs.

Summary of Significant Accoun21

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Oct. 31, 2015
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation As of October 31, 2015, Burlington Stores, Inc. and its subsidiaries (the Company), a Delaware Corporation, through its indirect subsidiary Burlington Coat Factory Warehouse Corporation (BCFWC), operated 566 retail stores, inclusive of an internet store. These unaudited Condensed Consolidated Financial Statements include the accounts of Burlington Stores, Inc. and its subsidiaries. All inter-company accounts and transactions have been eliminated in consolidation. The Condensed Consolidated Financial Statements are unaudited, but in the opinion of management reflect all adjustments (which are of a normal and recurring nature) necessary for the fair presentation of the results of operations for the interim periods presented. Certain information and note disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) have been condensed or omitted. It is suggested that these Condensed Consolidated Financial Statements be read in conjunction with the audited Consolidated Financial Statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended January 31, 2015 (Fiscal 2014 10-K). The balance sheet at January 31, 2015 presented herein has been derived from the audited Consolidated Financial Statements contained in the Fiscal 2014 10-K. Because the Company’s business is seasonal in nature, the operating results for the three and nine month periods ended October 31, 2015 are not necessarily indicative of results for the fiscal year ending January 30, 2016 (Fiscal 2015). Accounting policies followed by the Company are described in Note 1 to the Fiscal 2014 10-K, “Summary of Significant Accounting Policies.” In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2014-09, “Revenue from Contracts with Customers,” which provides guidance for revenue recognition. The standard’s core principle is that a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. In doing so, companies will need to use more judgment and make more estimates than under current guidance. These may include identifying performance obligations in the contract, estimating the amount of variable consideration included in the transaction price and allocating the transaction price to each separate performance obligation. At its July 9, 2015 meeting, the FASB affirmed its proposal to defer the effective date of this ASU for reporting periods beginning after December 15, 2017, with early adoption permitted for annual reporting periods beginning on or after December 15, 2016, and interim periods within those annual periods. The effective date of this ASU for the Company is February 4, 2018. The Company is currently in the process of evaluating the impact of adoption of this ASU on its Consolidated Financial Statements. In April 2015, the FASB issued ASU 2015-03, “Interest—Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs.” This standard amends existing guidance to require the presentation of debt issuance costs in the balance sheet as a deduction from the carrying amount of the related debt liability. This ASU is effective for fiscal years beginning after December 15, 2015, with early adoption permitted. The Company intends to adopt this ASU during the fiscal year beginning on January 31, 2016. The Company does not expect this standard to have a significant effect on its Consolidated Financial Statements. There were no other new accounting standards that had a material impact on the Company’s Condensed Consolidated Financial Statements during the three and nine month periods ended October 31, 2015, and there were no other new accounting standards or pronouncements that were issued but not yet effective as of October 31, 2015 that the Company expects to have a material impact on its financial position or results of operations upon becoming effective.
Secondary Offering	Secondary Offering On April 7, 2015, the Company closed a secondary public offering of 12,490,154 shares of its common stock (the Secondary Offering). All of the shares sold in the Secondary Offering were offered by selling stockholders. The Company did not receive any of the proceeds from the Secondary Offering. The Company incurred $0.2 million in offering costs related to the Secondary Offering, which are included in the line item “Costs related to debt amendments, secondary offerings and other” on the Company’s Condensed Consolidated Statements of Operations.

Long Term Debt (Tables)

Long Term Debt (Tables)	9 Months Ended
	Oct. 31, 2015
Debt Disclosure [Abstract]
Long Term Debt	Long term debt consists of: (in thousands) October 31, January 31, November 1, 2015 2015 2014 $1,200,000 senior secured term loan facility (Term B-3 Loans), LIBOR (with a floor of 1.0%) plus 3.25%, matures on August 13, 2021 $ 1,112,376 $ 1,161,541 $ 1,191,194 $600,000 ABL senior secured revolving facility, LIBOR plus spread based on average outstanding balance, matures August 13, 2019 276,200 63,300 205,200 Capital lease obligations 25,231 25,602 27,719 Total debt 1,413,807 1,250,443 1,424,113 Less: current maturities (1,376 ) (1,167 ) (13,275 ) Long term debt, net of current maturities $ 1,412,431 $ 1,249,276 $ 1,410,838

Derivative Instruments and He23

Derivative Instruments and Hedging Activities (Tables)	9 Months Ended
	Oct. 31, 2015
Fair Value of Company's Derivative Financial Instruments on Gross Basis as well as Classification	The tables below present the fair value of the Company’s derivative financial instruments on a gross basis as well as their classification on the Company’s Condensed Consolidated Balance Sheets: (in thousands) Fair Values of Derivative Instruments Asset Derivatives October 31, 2015 January 31, 2015 November 1, 2014 Derivatives Designated as Hedging Instruments Balance Sheet Location Fair Value Balance Sheet Location Fair Value Balance Sheet Location Fair Value Interest rate cap contracts N/A $ — Other assets $ 1,572 Other assets $ 3,237 (in thousands) Fair Values of Derivative Instruments Liability Derivatives October 31, 2015 January 31, 2015 November 1, 2014 Derivatives Designated as Hedging Instruments Balance Sheet Location Fair Value Balance Sheet Location Fair Value Balance Sheet Location Fair Value Interest rate cap contracts Other $ 4,331 N/A $ — N/A $ — The tables below present the amounts of losses recognized in other comprehensive loss, net of taxes, and the classification of losses reclassified into earnings related to the Company’s derivative instruments designated as cash flow hedging instruments for each of the reporting periods. (in thousands) Amount of Losses Recognized in Other Comprehensive Loss Related to Derivatives Derivatives Designated as Three Months Ended Nine Months Ended Hedging Instruments October 31, 2015 November 1, 2014 October 31, 2015 November 1, 2014 Interest rate cap contracts $ (3,358 ) $ (745 ) $ (4,179 ) $ (745 ) (in thousands) Amount of Loss Reclassified from Accumulated Other Comprehensive Loss into Earnings Related to Derivatives Derivatives Designated as Three Months Ended Nine Months Ended Component of Hedging Instruments October 31, 2015 November 1, 2014 October 31, 2015 November 1, 2014 Earnings Interest rate cap contracts $ 55 $ — $ 79 $ — Interest The table below presents the classification of losses recognized within our statements of operations for the Company’s derivative instruments not designated as hedging instruments for each of the reporting periods. (in thousands) Amount of Loss Recognized in Earnings Location of Loss Recognized in Earnings Three Months Ended Nine Months Ended Derivatives Not Designated as Hedging Instruments Related to Derivatives October 31, 2015 November 1, 2014 October 31, 2015 November 1, 2014 Interest rate cap contracts Interest expense $ — $ — $ — $ 1
Derivatives Designated as Hedging Instruments
Outstanding Interest Rate Derivatives in Qualifying Hedging Relationships	As of October 31, 2015, the Company had the following outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk: Interest Rate Derivative Number of Instruments Notional Aggregate Principal Amount Interest Cap Rate Effective Date Maturity Date Interest rate cap contracts Two $ 800.0 million 1.0% May 29, 2015 May 31, 2019

Accumulated Other Comprehensi24

Accumulated Other Comprehensive Loss (Tables)	9 Months Ended
	Oct. 31, 2015
Equity [Abstract]
Changes in Accumulated Other Comprehensive Loss	The following table details the changes in accumulated other comprehensive loss: (in thousands) Derivative Instruments Total Balance at January 31, 2015 $ (1,744 ) $ (1,744 ) Unrealized losses arising during the period, net of related tax benefit of $2.8 million for the nine months ended October 31, 2015 (4,179 ) (4,179 ) Amount reclassified into earnings, net of related taxes of $0.1 million for the nine months ended October 31, 2015 79 79 Balance at October 31, 2015 $ (5,844 ) $ (5,844 )

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Oct. 31, 2015
Fair Value Disclosures [Abstract]
Fair Values of Financial Assets and Hierarchy of Level of Inputs	The fair values of the Company’s financial assets and the hierarchy of the level of inputs as of October 31, 2015, January 31, 2015 and November 1, 2014 are summarized below: (in thousands) Fair Value Measurements at October 31, January 31, November 1, 2015 2015 2014 Assets: Level 1 Cash equivalents (including restricted cash) $ 28,109 $ 28,094 $ 32,349
Fair Value of Remaining, Partially-Impaired Store, Subsequent to Impairment Charges	The table below sets forth, by level within the fair value hierarchy, the fair value of the remaining, partially-impaired store, subsequent to impairment charges as of October 31, 2015: (in thousands) Quoted in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Un- Observable Inputs (Level 3) Total Total Impairment Losses Leasehold improvements $ — $ — $ 388 $ 388 $ 766 Building/Building Improvements — — — — 12 Furniture and fixtures — — 341 341 645 Other assets — — 237 237 320 Other property and equipment — — 19 19 160 Total $ — $ — $ 985 $ 985 $ 1,903
Fair Values of Financial Liabilities	The fair values of the Company’s financial liabilities are summarized below: (in thousands) October 31, 2015 January 31, 2015 November 1, 2014 Carrying Amount (b) Fair Value (b) Carrying Amount (b) Fair Value (b) Carrying Amount (b) Fair Value (b) $1,200,000 senior secured term loan facility (Term B-3 Loans), LIBOR (with a floor of 1.0%) plus 3.25%, matures on August 13, 2021 $ 1,112,376 $ 1,114,210 $ 1,161,541 $ 1,150,410 $ 1,191,194 $ 1,185,715 $600,000 ABL senior secured revolving facility, LIBOR plus spread based on average outstanding balance, expires August 13, 2019(a) 276,200 276,200 63,300 63,300 205,200 205,200 Total debt $ 1,388,576 $ 1,390,410 $ 1,224,841 $ 1,213,710 $ 1,396,394 $ 1,390,915 (a) To the extent the Company has any outstanding borrowings under the ABL Line of Credit, the fair value would approximate its reported value because the interest rate is variable and reflects current market rates due to its short term nature (borrowings are typically done in 30 day increments). (b) Capital lease obligations are excluded from the table above.

Income Taxes (Tables)

Income Taxes (Tables)	9 Months Ended
	Oct. 31, 2015
Income Tax Disclosure [Abstract]
Net Deferred Taxes	Net deferred taxes are as follows: (in thousands) October 31, January 31, November 1, 2015 2015 2014 Current deferred tax asset $ 36,934 $ 37,229 $ 18,216 Non-current deferred tax liability 209,330 234,360 217,189 Net deferred tax liability $ 172,396 $ 197,131 $ 198,973

Net Income (Loss) Per Share (Ta

Net Income (Loss) Per Share (Tables)	9 Months Ended
	Oct. 31, 2015
Earnings Per Share [Abstract]
Computation of Basic and Diluted per Common Share	Basic net income (loss) per share is calculated by dividing net income (loss) by the weighted-average common shares outstanding. Dilutive net income (loss) per share is calculated by dividing net income (loss) by the weighted-average common shares and potentially dilutive securities outstanding during the period using the treasury stock method. (in thousands, except per share data) Three Months Ended Nine Months Ended October 31, November 1, October 31, November 1, 2015 2014 2015 2014 Basic net income (loss) per share Net income (loss) $ 15,116 $ (34,214 ) $ 51,709 $ (28,910 ) Weighted average number of common shares – basic 74,115 74,218 74,759 73,943 Net income (loss) per common share – basic $ 0.20 $ (0.46 ) $ 0.69 $ (0.39 ) Diluted net income (loss) per share Net income (loss) $ 15,116 $ (34,214 ) $ 51,709 $ (28,910 ) Shares for basic and diluted net income (loss) per share: Weighted average number of common shares – basic 74,115 74,218 74,759 73,943 Assumed exercise of stock options and vesting of restricted stock 1,279 — 1,376 — Weighted average number of common shares – diluted 75,394 74,218 76,135 73,943 Net income (loss) per common share – diluted $ 0.20 $ (0.46 ) $ 0.68 $ (0.39 )

Stock Option and Award Plans 28

Stock Option and Award Plans and Stock-Based Compensation (Tables)	9 Months Ended
	Oct. 31, 2015
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Non-Cash Stock Compensation Expense	Non-cash stock compensation expense is as follows: (in thousands) Three Months Ended Nine Months Ended October 31, November 1, October 31, November 1, Type of Non-Cash Stock Compensation 2015 2014 2015 2014 Restricted stock grants (a) $ 1,623 $ 247 $ 4,574 $ 528 Stock option grants (a) 1,099 730 2,764 2,201 Stock option modification (b) 257 487 899 1,887 Total (c) $ 2,979 $ 1,464 $ 8,237 $ 4,616 (a) Included in the line item “Selling, general and administrative expenses” in the Company’s Condensed Consolidated Statements of Operations. (b) Represents non-cash compensation related to the May 2013 stock option modification as discussed above. Amounts are included in the line item “Stock option modification expense” in the Company’s Condensed Consolidated Statements of Operations. (c) The amounts presented in the table above exclude taxes. For the three and nine month periods ended October 31, 2015, the tax benefit related to the Company’s non-cash stock compensation was approximately $1.1 million and $3.2 million, respectively. For the three and nine month periods ended November 1, 2014, the tax benefit related to the Company’s non-cash stock compensation was approximately $0.6 million and $1.9 million, respectively.
Stock Option Transactions	Stock option transactions during the nine month period ended October 31, 2015 are summarized as follows: Number of Shares Weighted Average Exercise Price Per Share Options outstanding, January 31, 2015 3,218,845 $ 4.93 Options granted 411,060 52.31 Options exercised (a) (538,043 ) 3.58 Options forfeited (262,311 ) 4.30 Options outstanding, October 31, 2015 2,829,551 $ 12.12 (a) Options exercised during the nine month period ended October 31, 2015 had a total intrinsic value of $28.2 million.
Stock Options Vested and Expected to Vest	The following table summarizes information about the stock options vested and expected to vest during the contractual term as of October 31, 2015: Options Weighted Average Remaining Contractual Life (Years) Weighted Average Exercise Price Aggregate Intrinsic Value Vested and expected to vest 2,475,965 7.43 $ 11.87 $ 91.1 million
Weighted Average Assumptions Used to Estimate Fair Value of Each Stock Option Granted	The fair value of each stock option granted during the nine month period ended October 31, 2015 was estimated using the Black Scholes option pricing model using the following assumptions: Nine Months Ended October 31, 2015 Risk-fee interest rate 1.81% Expected volatility 36.0% Expected life (years) 6.25 Contractual life (years) 10.0 Expected dividend yield 0.0% Weighted average grant date fair value of options issued $ 19.99
Award Grant and Vesting Transactions	Restricted stock transactions during the nine month period ended October 31, 2015 are summarized as follows: Number of Shares Weighted Average Grant Date Fair Value Per Awards Non-vested awards outstanding, January 31, 2015 392,178 $ 38.56 Awards granted 172,276 52.07 Awards vested (62,683 ) 40.76 Awards forfeited (38,760 ) 13.81 Non-vested awards outstanding, October 31, 2015 463,011 $ 45.36

Summary of Significant Accoun29

Summary of Significant Accounting Policies - Additional Information (Detail)	Apr. 07, 2015USD ($)shares	Oct. 31, 2015Store
Summary Of Significant Accounting Policies [Line Items]
Number of stores | Store		566
Secondary Offering
Summary Of Significant Accounting Policies [Line Items]
Shares issued | shares	12,490,154
Proceeds from the sale of shares	$ 0
Offering cost	$ 200,000

Long-Term Debt (Detail)

Long-Term Debt (Detail) - USD ($) $ in Thousands	Oct. 31, 2015	Jan. 31, 2015	Nov. 01, 2014
Debt Instrument [Line Items]
Capital lease obligations	$ 25,231	$ 25,602	$ 27,719
Total debt	1,413,807	1,250,443	1,424,113
Less: current maturities	(1,376)	(1,167)	(13,275)
Long term debt, net of current maturities	1,412,431	1,249,276	1,410,838
ABL senior secured revolving facility
Debt Instrument [Line Items]
Long Term Debt	276,200	63,300	205,200
senior secured term loans | Term B-3 Loans
Debt Instrument [Line Items]
Long Term Debt	$ 1,112,376	$ 1,161,541	$ 1,191,194

Long-Term Debt (Parenthetical)

Long-Term Debt (Parenthetical) (Detail) - USD ($) $ in Thousands	9 Months Ended		12 Months Ended
	Oct. 31, 2015	Nov. 01, 2014	Jan. 31, 2015
Term B-3 Loans
Debt Instrument [Line Items]
Long-Term Debt, maturity date	Aug. 13, 2021
ABL senior secured revolving facility
Debt Instrument [Line Items]
Long-Term Debt, maturity date	Aug. 13, 2019	Aug. 13, 2019	Aug. 13, 2019
Long-Term Debt, face amount	$ 600,000	$ 600,000	$ 600,000
senior secured term loans | Term B-3 Loans
Debt Instrument [Line Items]
Long-Term Debt, maturity date	Aug. 13, 2021	Aug. 13, 2021	Aug. 13, 2021
Long-Term Debt, face amount	$ 1,200,000	$ 1,200,000	$ 1,200,000
London Interbank Offered Rate Floor | senior secured term loans | Term B-3 Loans
Debt Instrument [Line Items]
Long-Term Debt, interest rate	1.00%	1.00%	1.00%
London Interbank Offered Rate (LIBOR) | senior secured term loans | Term B-3 Loans
Debt Instrument [Line Items]
Long-Term Debt, interest rate	3.25%	3.25%	3.25%

Long-Term Debt - Additional Inf

Long-Term Debt - Additional Information (Detail) - USD ($)	May. 01, 2015	Aug. 13, 2014	Jul. 29, 2017	Oct. 31, 2015	Nov. 01, 2014	Oct. 31, 2015	Nov. 01, 2014	Jan. 31, 2015
Debt Instrument [Line Items]
Long-Term Debt, payment							$ 450,000,000
Loss on Extinguishment of Debt					$ (70,302,000)	$ (649,000)	$ (73,983,000)
Term B-3 Loans
Debt Instrument [Line Items]
Long-Term Debt, date of first installment						Jul. 29, 2017
Long-Term Debt, frequency of periodic payment						Mandatory quarterly payments of $3.0 million were payable as of the last day of each quarter, beginning with the quarter ended July 29, 2017.
Long-Term Debt, maturity date						Aug. 13, 2021
Long-Term Debt, payment	$ 50,000,000
Mandatory quarterly payments due date						May 1, 2021
Loss on Extinguishment of Debt						$ (600,000)
Write-off in deferred financing costs						400,000
Write-off unamortized original issue discount				$ 200,000		$ 200,000
Term B-3 Loans | Scenario, Forecast
Debt Instrument [Line Items]
Term loan facility, quarterly payments			$ 3,000,000
Senior Secured Term Loan Facilities
Debt Instrument [Line Items]
Borrowing, interest rate				4.25%		4.25%
Senior Secured Term Loan Facilities | Adjusted London Interbank Offered Rate
Debt Instrument [Line Items]
Line of Credit Facility, interest rate						1.00%
Senior Secured Term Loan Facilities | Federal Funds Rate
Debt Instrument [Line Items]
Line of Credit Facility, interest rate						0.50%
Senior Secured Term Loan Facilities | One Month Adjusted London Interbank Offered Rate
Debt Instrument [Line Items]
Line of Credit Facility, interest rate						1.00%
ABL senior secured revolving facility
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity		$ 600,000,000
Long-Term Debt, maturity date						Aug. 13, 2019	Aug. 13, 2019	Aug. 13, 2019
Line of Credit Facility, amount available				$ 278,200,000	346,300,000	$ 278,200,000	$ 346,300,000
Line of Credit Facility, amount outstanding				276,200,000	205,200,000	276,200,000	205,200,000	$ 63,300,000
Line of Credit Facility, maximum amount outstanding during period				330,700,000	297,000,000	330,700,000	297,000,000
Line of Credit Facility, Average borrowings				$ 270,200,000	$ 226,500,000	$ 199,700,000	$ 83,800,000
Line of Credit Facility, Average interest rate				1.60%	1.70%	1.60%	1.70%
Amended ABL senior secured revolving facility
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity		$ 900,000,000
Line of Credit Facility, unused loan commitments		0.25%
London Interbank Offered Rate (LIBOR) | Amended ABL senior secured revolving facility | Minimum
Debt Instrument [Line Items]
Line of Credit Facility, interest rate		1.25%
London Interbank Offered Rate (LIBOR) | Amended ABL senior secured revolving facility | Maximum
Debt Instrument [Line Items]
Line of Credit Facility, interest rate		1.50%
Fourth Amendment | Amended Term Loan Credit Agreement
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity		$ 400,000,000
Line of Credit Facility, maximum consolidated secured leverage ratio		3.50%
Fourth Amendment | London Interbank Offered Rate (LIBOR) | Amended Term Loan Credit Agreement
Debt Instrument [Line Items]
Line of Credit Facility, interest rate		3.25%
Fourth Amendment | Prime Rate | Amended Term Loan Credit Agreement
Debt Instrument [Line Items]
Line of Credit Facility, interest rate		2.25%

Derivative Instruments And He33

Derivative Instruments And Hedging Activities - Additional Information (Detail)	Apr. 24, 2015USD ($)Derivative	Oct. 31, 2015USD ($)Derivative	Nov. 01, 2014USD ($)	Oct. 31, 2015USD ($)Derivative	Nov. 01, 2014USD ($)	Aug. 19, 2014Derivative
Derivative [Line Items]
Proceeds from termination of Previous Interest Rate Cap Contracts				$ 1,169,000
Amount of loss previously deferred in accumulated other comprehensive loss related to caps		$ 3,358,000	$ 745,000	4,179,000	$ 745,000
Amount of loss previously deferred in accumulated other comprehensive loss related to caps, tax		(2,200,000)	$ (500,000)	(2,800,000)	(500,000)
Amount related to new interest rate cap contracts				2,399,000	$ 13,585,000
Amount reclassified into earnings, net of related taxes of less than $0.1 million and $0.1 million for the three and nine months ended October 31, 2015, respectively.		$ 55,000		$ 79,000
Derivatives Not Designated as Hedging Instruments
Derivative [Line Items]
Number of Instruments | Derivative		2		2
Interest Cap Rate		7.00%		7.00%
Aggregate notional principal amount		$ 900,000,000		$ 900,000,000
Maturity Date				May 31, 2015
Interest rate cap
Derivative [Line Items]
Interest rate cap contracts, number | Derivative	2					4
Proceeds from termination of Previous Interest Rate Cap Contracts	$ 1,200,000
Amount of loss previously deferred in accumulated other comprehensive loss related to caps	2,000,000
Amount of loss previously deferred in accumulated other comprehensive loss related to caps, tax	$ 1,300,000
Loss amortization period	2019-04
Amount related to new interest rate cap contracts				$ 2,200,000
Ineffective portion of change in fair value of derivatives		0		0
Amount reclassified into earnings, net of related taxes of less than $0.1 million and $0.1 million for the three and nine months ended October 31, 2015, respectively.		100,000		$ 100,000
Amounts reported in Accumulated Other Comprehensive Loss to be reclassified to interest expense, during the next twelve months		$ 1,600,000

Outstanding Interest Rate Deriv

Outstanding Interest Rate Derivatives in Qualifying Hedging Relationships (Detail) - Cash Flow Hedging - Derivatives Designated as Hedging Instruments - Interest Rate Cap Contract One	9 Months Ended
	Oct. 31, 2015USD ($)Derivative
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Number of Instruments | Derivative	2
Notional Aggregate Principal Amount	$ 800,000,000
Interest Cap Rate	1.00%
Effective Date	May 29, 2015
Maturity Date	May 31, 2019

Derivative Instruments and He35

Derivative Instruments and Hedging Activities (Detail) - Interest rate cap - USD ($) $ in Thousands	Oct. 31, 2015	Jan. 31, 2015	Nov. 01, 2014
Other Assets
Derivatives, Fair Value [Line Items]
Derivative Designated as Hedging Instruments Interest Rate Cap Contracts, Asset at Fair Value		$ 1,572	$ 3,237
Other Liabilities
Derivatives, Fair Value [Line Items]
Derivative Designated as Hedging Instruments Interest Rate Cap Contracts, Liability at Fair Value	$ 4,331

Amounts of Losses Recognized in

Amounts of Losses Recognized in Other Comprehensive Loss Net of Taxes and Classifications and Amounts of Losses Reclassified Into Earnings (Detail) - Derivatives Designated as Hedging Instruments - Interest rate cap - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2015	Nov. 01, 2014	Oct. 31, 2015	Nov. 01, 2014
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Loss Recognized in Other Comprehensive Income Related to Derivatives	$ (3,358)	$ (745)	$ (4,179)	$ (745)
Interest expense
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Loss Reclassified from Other Comprehensive Loss into Earnings Related to Derivatives	$ 55		$ 79

Classifications and Amounts Of

Classifications and Amounts Of Losses Recognized Of Derivative Instruments Not Designated as Hedging Instruments (Detail) $ in Thousands	9 Months Ended
	Nov. 01, 2014USD ($)
Derivatives Not Designated as Hedging Instruments | Interest rate cap | Interest expense
Derivative [Line Items]
Derivative Not Designated as Hedging Instruments Interest Rate Cap Contracts, (Gain) Loss Recognized	$ 1

Changes in Accumulated Other Co

Changes in Accumulated Other Comprehensive Loss (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2015	Nov. 01, 2014	Oct. 31, 2015	Nov. 01, 2014
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning Balance			$ (1,744)
Unrealized losses arising during the period, net of related tax benefit of $2.8 million for the nine months ended October 31, 2015	$ (3,358)	$ (745)	(4,179)	$ (745)
Amount reclassified into earnings, net of related taxes of $0.1 million for the nine months ended October 31, 2015	55		79
Ending Balance	(5,844)	$ (745)	(5,844)	$ (745)
Derivative Instruments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning Balance			(1,744)
Unrealized losses arising during the period, net of related tax benefit of $2.8 million for the nine months ended October 31, 2015			(4,179)
Amount reclassified into earnings, net of related taxes of $0.1 million for the nine months ended October 31, 2015			79
Ending Balance	$ (5,844)		$ (5,844)

Changes in Accumulated Other 39

Changes in Accumulated Other Comprehensive Loss (Parenthetical) (Detail) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2015	Nov. 01, 2014	Oct. 31, 2015	Nov. 01, 2014
Accumulated Other Comprehensive Income (Loss) [Line Items]
Unrealized losses on Interest Rate Cap Contracts, Tax Benefit	$ 2.2	$ 0.5	$ 2.8	$ 0.5
Amount reclassified into earnings, Tax			0.1
Derivative Instruments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Unrealized losses on Interest Rate Cap Contracts, Tax Benefit			2.8
Amount reclassified into earnings, Tax			$ 0.1

Fair Values of Financial Assets

Fair Values of Financial Assets and Hierarchy of Level of Inputs (Detail) - USD ($) $ in Thousands	Oct. 31, 2015	Jan. 31, 2015	Nov. 01, 2014
Fair Value, Inputs, Level 1
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Cash equivalents (including restricted cash)	$ 28,109	$ 28,094	$ 32,349

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Detail) $ in Thousands	3 Months Ended	9 Months Ended
	Nov. 01, 2014USD ($)	Oct. 31, 2015USD ($)Store	Nov. 01, 2014USD ($)
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Impairment charges-long-lived assets	$ 6	$ 1,903	$ 853
Number of stores that primarily contributed to impairment charges | Store		2
Currently Impaired Stores
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Impairment charges-long-lived assets		$ 1,700
Previously Impaired Stores
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Impairment charges-long-lived assets		200
Fair Value, Inputs, Level 3
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Asset fair value		$ 0

Fair Value of Remaining, Partia

Fair Value of Remaining, Partially-Impaired Store, Subsequent to Impairment Charges (Detail) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Nov. 01, 2014	Oct. 31, 2015	Nov. 01, 2014
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Asset Impairment charges	$ 6	$ 1,903	$ 853
Fair Value, Inputs, Level 3
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Asset fair value		0
Fair Value, Measurements, Nonrecurring | Partially-Impaired Store
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Asset fair value		985
Asset Impairment charges		1,903
Fair Value, Measurements, Nonrecurring | Fair Value, Inputs, Level 3 | Partially-Impaired Store
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Asset fair value		985
Fair Value, Measurements, Nonrecurring | Leasehold Improvements | Partially-Impaired Store
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Asset fair value		388
Asset Impairment charges		766
Fair Value, Measurements, Nonrecurring | Leasehold Improvements | Fair Value, Inputs, Level 3 | Partially-Impaired Store
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Asset fair value		388
Fair Value, Measurements, Nonrecurring | Building/Building Improvements | Partially-Impaired Store
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Asset Impairment charges		12
Fair Value, Measurements, Nonrecurring | Furniture and Fixtures | Partially-Impaired Store
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Asset fair value		341
Asset Impairment charges		645
Fair Value, Measurements, Nonrecurring | Furniture and Fixtures | Fair Value, Inputs, Level 3 | Partially-Impaired Store
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Asset fair value		341
Fair Value, Measurements, Nonrecurring | Other Assets | Partially-Impaired Store
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Asset fair value		237
Asset Impairment charges		320
Fair Value, Measurements, Nonrecurring | Other Assets | Fair Value, Inputs, Level 3 | Partially-Impaired Store
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Asset fair value		237
Fair Value, Measurements, Nonrecurring | Other Property and Equipment | Partially-Impaired Store
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Asset fair value		19
Asset Impairment charges		160
Fair Value, Measurements, Nonrecurring | Other Property and Equipment | Fair Value, Inputs, Level 3 | Partially-Impaired Store
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Asset fair value		$ 19

Fair Values of Financial Liabil

Fair Values of Financial Liabilities (Detail) - USD ($) $ in Thousands		Oct. 31, 2015	Jan. 31, 2015	Nov. 01, 2014
Carrying Amounts And Fair Values Of Financial Instruments [Line Items]
Long-Term Debt, Carrying Amount	[1]	$ 1,388,576	$ 1,224,841	$ 1,396,394
Long-Term Debt, Fair Value	[1]	1,390,410	1,213,710	1,390,915
ABL senior secured revolving facility
Carrying Amounts And Fair Values Of Financial Instruments [Line Items]
Long-Term Debt, Carrying Amount	[1],[2]	276,200	63,300	205,200
Long-Term Debt, Fair Value	[1],[2]	276,200	63,300	205,200
senior secured term loans | Term B-3 Loans
Carrying Amounts And Fair Values Of Financial Instruments [Line Items]
Long-Term Debt, Carrying Amount	[1]	1,112,376	1,161,541	1,191,194
Long-Term Debt, Fair Value	[1]	$ 1,114,210	$ 1,150,410	$ 1,185,715
[1]	Capital lease obligations are excluded from the table above.
[2]	To the extent the Company has any outstanding borrowings under the ABL Line of Credit, the fair value would approximate its reported value because the interest rate is variable and reflects current market rates due to its short term nature (borrowings are typically done in 30 day increments).

Fair Values of Financial Liab44

Fair Values of Financial Liabilities (Parenthetical) (Detail) - USD ($) $ in Thousands	9 Months Ended		12 Months Ended
	Oct. 31, 2015	Nov. 01, 2014	Jan. 31, 2015
Carrying Amounts And Fair Values Of Financial Instruments [Line Items]
Borrowings increments number of days	30 days
ABL senior secured revolving facility
Carrying Amounts And Fair Values Of Financial Instruments [Line Items]
Long-Term Debt, maturity date	Aug. 13, 2019	Aug. 13, 2019	Aug. 13, 2019
Long-Term Debt, face amount	$ 600,000	$ 600,000	$ 600,000
Long-Term Debt, expiration date	Aug. 13, 2019	Aug. 13, 2019	Aug. 13, 2019
Term B-3 Loans
Carrying Amounts And Fair Values Of Financial Instruments [Line Items]
Long-Term Debt, maturity date	Aug. 13, 2021
Term B-3 Loans | senior secured term loans
Carrying Amounts And Fair Values Of Financial Instruments [Line Items]
Long-Term Debt, maturity date	Aug. 13, 2021	Aug. 13, 2021	Aug. 13, 2021
Long-Term Debt, face amount	$ 1,200,000	$ 1,200,000	$ 1,200,000
Term B-3 Loans | senior secured term loans | London Interbank Offered Rate Floor
Carrying Amounts And Fair Values Of Financial Instruments [Line Items]
Long-Term Debt, interest rate	1.00%	1.00%	1.00%
Term B-3 Loans | senior secured term loans | London Interbank Offered Rate (LIBOR)
Carrying Amounts And Fair Values Of Financial Instruments [Line Items]
Long-Term Debt, interest rate	3.25%	3.25%	3.25%

Net Deferred Taxes (Detail)

Net Deferred Taxes (Detail) - USD ($) $ in Thousands	Oct. 31, 2015	Jan. 31, 2015	Nov. 01, 2014
Income Tax Disclosure [Abstract]
Current deferred tax asset	$ 36,934	$ 37,229	$ 18,216
Non-current deferred tax liability	209,330	234,360	217,189
Net deferred tax liability	$ 172,396	$ 197,131	$ 198,973

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) - USD ($) $ in Millions	9 Months Ended
	Oct. 31, 2015	Jan. 31, 2015	Nov. 01, 2014
Income Tax Disclosure [Line Items]
Full valuation allowance	$ 5.4	$ 4.5	$ 3.8
State and local jurisdiction
Income Tax Disclosure [Line Items]
Valuation allowances	6.2	$ 6.1	$ 5.7
Deferred tax asset for net operating loss	7.4
Deferred tax assets subject to expire	$ 5.6
State and local jurisdiction | Minimum
Income Tax Disclosure [Line Items]
Net operating losses subject to expiration year	2,015
State and local jurisdiction | Maximum
Income Tax Disclosure [Line Items]
Net operating losses subject to expiration year	2,025

Capital Stock - Additional Info

Capital Stock - Additional Information (Detail) - USD ($)	Nov. 24, 2015	Jun. 09, 2015	Oct. 31, 2015	Jan. 31, 2015	Nov. 01, 2014
Statement Equity Components [Line Items]
Shares Used for Tax Withholdings (in shares)			23,620
Shares Used for Tax Withholdings			$ 1,200,000
Common stock repurchased, value			$ 132,389,000	$ 8,258,000	$ 7,411,000
2015 Stock Repurchase Program
Statement Equity Components [Line Items]
Stock repurchase program, authorized amount		$ 200,000,000
Stock repurchase program, authorized execution month and year		2017-06
Common stock repurchased, shares			2,342,414
Common stock repurchased, value			$ 123,000,000
Remaining authorized repurchase amount			$ 77,000,000
2015 Stock Repurchase Program | Subsequent Event
Statement Equity Components [Line Items]
Stock repurchase program, authorized amount	$ 200,000,000
Stock repurchase program, authorized execution month and year	2017-11

Computation of Basic and Dilute

Computation of Basic and Diluted per Common Share (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2015	Nov. 01, 2014	Oct. 31, 2015	Nov. 01, 2014
Basic net income (loss) per share
Net income (loss)	$ 15,116	$ (34,214)	$ 51,709	$ (28,910)
Weighted average number of common shares – basic	74,115	74,218	74,759	73,943
Net income (loss) per common share – basic	$ 0.20	$ (0.46)	$ 0.69	$ (0.39)
Diluted net income (loss) per share
Net income (loss)	$ 15,116	$ (34,214)	$ 51,709	$ (28,910)
Weighted average number of common shares – basic	74,115	74,218	74,759	73,943
Assumed exercise of stock options and vesting of restricted stock	1,279		1,376
Weighted average number of common shares – diluted	75,394	74,218	76,135	73,943
Net income (loss) per common share – diluted	$ 0.20	$ (0.46)	$ 0.68	$ (0.39)

Net Income (Loss) Per Share - A

Net Income (Loss) Per Share - Additional Information (Detail) - Maximum - shares	Nov. 01, 2014	Oct. 31, 2015	Oct. 31, 2015
Stock Option
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Awards excluded from diluted earnings per share	3,777,194	150,000	100,000
Restricted Stock Issuances
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Awards excluded from diluted earnings per share	163,278	150,000	100,000

Stock Option and Award Plans 50

Stock Option and Award Plans and Stock-Based Compensation - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Millions	1 Months Ended	3 Months Ended			9 Months Ended		12 Months Ended
	Feb. 28, 2013	Oct. 31, 2015	Nov. 01, 2014	Aug. 03, 2013	Oct. 31, 2015	Nov. 01, 2014	Feb. 03, 2018	Jan. 31, 2015
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Payment of Dividends	$ 336
Incremental compensation expense from modification		$ 0.3	$ 0.6		$ 1.1	$ 2.4
Stock option modification payable			$ 0.1			$ 0.5
Options outstanding		2,829,551			2,829,551			3,218,845
Restricted Stock Issuances
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Percentage of shares vested if change in control					100.00%
Maximum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock option modification payable		$ 0.1			$ 0.2
Maximum | Restricted Stock Issuances
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Service-based awards, service period					4 years
Minimum | Restricted Stock Issuances
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Service-based awards, service period					3 years
Scenario, Forecast
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Incremental compensation expense from modification							$ 1
Stock option modification payable							$ 0.1
Holdco notes
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Aggregate principal amount of senior notes	$ 350
2006 Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Common stock, Authorized for issuance		10,125,258			10,125,258
Options granted, exercise price lower range					$ 51.81	$ 27.40
Options granted, exercise price upper range					$ 55.75	$ 38.66
Unexercised vested options, exercisable period					60 days
2006 Plan | One Time Grant
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Options granted, percentage vested				20.00%
Options vesting period					2 years
2006 Plan | Employee Stock Option
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Options outstanding		2,829,551			2,829,551
2006 Plan | Share Based Compensation Award Tranche One
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Service-based awards granted subsequent to offering vesting percentage on each of the first four anniversaries of the grant date					25.00%
2013 Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Common stock, Authorized for issuance		6,000,000			6,000,000
2013 Plan | Employee Stock Option
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Options outstanding		0			0

Non-Cash Stock Compensation Exp

Non-Cash Stock Compensation Expense (Detail) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Oct. 31, 2015	Nov. 01, 2014	Oct. 31, 2015	Nov. 01, 2014
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Non-Cash Stock Compensation	[1]	$ 2,979	$ 1,464	$ 8,237	$ 4,616
Restricted Stock Grants
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Non-Cash Stock Compensation	[2]	1,623	247	4,574	528
Stock Option Grants
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Non-Cash Stock Compensation	[2]	1,099	730	2,764	2,201
Stock Option Modification
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Non-Cash Stock Compensation	[3]	$ 257	$ 487	$ 899	$ 1,887
[1]	The amounts presented in the table above exclude taxes. For the three and nine month periods ended October 31, 2015, the tax benefit related to the Company’s non-cash stock compensation was approximately $1.1 million and $3.2 million, respectively. For the three and nine month periods ended November 1, 2014, the tax benefit related to the Company’s non-cash stock compensation was approximately $0.6 million and $1.9 million, respectively.
[2]	Included in the line item “Selling, general and administrative expenses” in the Company’s Condensed Consolidated Statements of Operations.
[3]	Represents non-cash compensation related to the May 2013 stock option modification as discussed above. Amounts are included in the line item “Stock option modification expense” in the Company’s Condensed Consolidated Statements of Operations.

Non-Cash Stock Compensation E52

Non-Cash Stock Compensation Expense (Parenthetical) (Detail) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2015	Nov. 01, 2014	Oct. 31, 2015	Nov. 01, 2014
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Non-Cash Stock Compensation tax benefit	$ 1.1	$ 0.6	$ 3.2	$ 1.9

Stock Option Transactions (Deta

Stock Option Transactions (Detail)	9 Months Ended
	Oct. 31, 2015$ / sharesshares
Number of Shares
Options Outstanding at Beginning of Period | shares	3,218,845
Options Granted | shares	411,060
Options Exercised | shares	(538,043)	[1]
Options Forfeited | shares	(262,311)
Options Outstanding at End of Period | shares	2,829,551
Weighted Average Exercise Price Per Share
Options Outstanding at Beginning of Period	$ 4.93
Options Granted	52.31
Options Exercised	3.58	[1]
Options Forfeited	4.30
Options Outstanding at End of Period	$ 12.12
[1]	Options exercised during the nine month period ended October 31, 2015 had a total intrinsic value of $28.2 million.

Stock Option Transactions (Pare

Stock Option Transactions (Parenthetical) (Detail) $ in Millions	9 Months Ended
	Oct. 31, 2015USD ($)
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Share based compensation option exercised total intrinsic value	$ 28.2

Stock Options Vested and Expect

Stock Options Vested and Expected to Vest (Detail) $ / shares in Units, $ in Millions	9 Months Ended
	Oct. 31, 2015USD ($)$ / sharesshares
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Options, vested and expected to vest | shares	2,475,965
Weighted Average Remaining Contractual Life (Years)	7 years 5 months 5 days
Weighted Average Exercise Price | $ / shares	$ 11.87
Aggregate Intrinsic Value	$ 91.1

Weighted Average Assumptions Us

Weighted Average Assumptions Used to Estimate Fair Value of Stock Option (Detail)	9 Months Ended
	Oct. 31, 2015$ / shares
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Risk-fee interest rate	1.81%
Expected volatility	36.00%
Expected life (years)	6 years 3 months
Contractual life (years)	10 years
Expected dividend yield	0.00%
Weighted average grant date fair value of options issued	$ 19.99

Award Grant, Vested and Forfeit

Award Grant, Vested and Forfeiture Transactions (Detail) - Non Vested Restricted Stock	9 Months Ended
	Oct. 31, 2015$ / sharesshares
Number of Shares
Non-Vested Awards Outstanding at Beginning of Period | shares	392,178
Awards Granted | shares	172,276
Awards Vested | shares	(62,683)
Awards Forfeited | shares	(38,760)
Non-Vested Awards Outstanding at End of Period | shares	463,011
Weighted Average Grant Date Fair Value Per Awards
Non-Vested Awards Outstanding at Beginning of Period	$ 38.56
Awards Granted	52.07
Awards Vested	40.76
Awards Forfeited	13.81
Non-Vested Awards Outstanding at End of Period	$ 45.36

Other Liabilities - Additional

Other Liabilities - Additional Information (Detail) - USD ($) $ in Millions	Oct. 31, 2015	Jan. 31, 2015	Nov. 01, 2014
Other Liabilities Disclosure [Abstract]
Deferred lease incentives	$ 165.7	$ 176.3	$ 158.8

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Detail) $ in Millions	9 Months Ended
	Oct. 31, 2015USD ($)Store	Jan. 31, 2015USD ($)	Nov. 01, 2014USD ($)	Nov. 30, 2005USD ($)
Commitments And Contingencies Disclosure [Line Items]
Aggregate losses related to litigation settlement	$ 29.4
Minimum lease payments for operating leases January 30, 2016	73.7
Minimum lease payments for operating leases January 28, 2017	305
Minimum lease payments for operating leases February 3, 2018	298.2
Minimum lease payments for operating leases February 2, 2019	273.9
Minimum lease payments for operating leases February 1, 2020	229
Minimum lease payments for operating leases thereafter	1,072.2
Letters of credit, outstanding amount	45.6	$ 48.1	$ 48.5
Purchase commitments related to goods or services	643.8
Death benefits				$ 1
Guarantee Performance Under Insurance And Utility Agreement
Commitments And Contingencies Disclosure [Line Items]
Letters of credit, outstanding amount	35.3	33.4	34.4
Merchandising Agreement
Commitments And Contingencies Disclosure [Line Items]
Letters of credit, outstanding amount	10.3	14.7	14.1
Letter of Credit
Commitments And Contingencies Disclosure [Line Items]
Letters of credit, outstanding amount	$ 278.2	$ 386.9	$ 346.3
Other Capitalized Property Plant and Equipment
Commitments And Contingencies Disclosure [Line Items]
Number of stores committed to be opened | Store	16
Options to Extend Lease Terms
Commitments And Contingencies Disclosure [Line Items]
Minimum lease payments	$ 105.3
New Stores | Other Capitalized Property Plant and Equipment
Commitments And Contingencies Disclosure [Line Items]
Minimum lease payments	$ 236.8

Subsequent Events - Additional

Subsequent Events - Additional Information (Detail) - 2015 Stock Repurchase Program - USD ($)	Nov. 24, 2015	Jun. 09, 2015
Subsequent Event [Line Items]
Stock repurchase program, authorized amount		$ 200,000,000
Stock repurchase program, authorized execution month and year		2017-06
Subsequent Event
Subsequent Event [Line Items]
Stock repurchase program, authorized amount	$ 200,000,000
Stock repurchase program, authorized execution month and year	2017-11